CORRECTION
Friday, 10 September, 2004
An article published on September 8, headlined 'Nucleonics challenges Benitec-CSIRO RNAI patent' contained errors relating to the timing of the filing of key patents.
It should have stated that a patent application by The Carnegie Institution of Washington and The University of Massachusetts (the Fire-Mello invention) was first filed in the US in December 1997. The Fire-Mello invention has an earlier priority date than the Benitec and CSIRO applications, which were first filed in Australia.
A patent application by Syngenta, directed to a vector for enhancing the inhibition of a selected target gene, was also filed before the Benitec and CSIRO applications.
Elevated blood protein levels predict mortality
Proteins that play key roles in the development of diseases such as cancer and inflammation may...
The microbiome helps to fight melanoma
Molecules produced by gut bacteria upon digestion of dietary fibre can improve the function of...
Heart implant brings hope to refractory angina patients
The coronary sinus reducer is understood to redistribute blood flow within the wall of the heart,...
